Lynch S, Kerlin P, Wall D, Ong T H, Shepherd R W, Cleghorn G J, Pillay S P, Powell L, Balderson G, O'Connor J
Queensland Liver Transplant Programme, Princess Alexandra Hospital, Woolloongabba.
Med J Aust. 1987 Oct 19;147(8):380-5.
Orthotopic liver transplantation began in Brisbane in January 1985. During the first two years of the programme an assessment committee evaluated 55 patients (38 adults, 17 children). Patients were either accepted for transplantation, rejected as unsuitable or deferred for elective reassessment. All of the 10 adults who were rejected for transplantation because they had "too advanced" disease died within four months of assessment. Six children who were accepted for transplantation died before a suitable donor liver could be found. In the first two years, 21 orthotopic liver transplantations were performed on 18 patients (adults, 13 patients; children, five patients). Fifteen of 21 grafts were procured from within Queensland. Twelve (67%) patients are alive at three to 23 months and all have been discharged from hospital. Deaths in adults were due to sepsis (three patients), aspiration pneumonitis (one patient), rejection and hepatic artery thrombosis (one patient) and the recurrence of a hepatocellular carcinoma five months after discharge from hospital (one patient). Two patients underwent a second transplantation procedure because of chronic rejection at four months and at 11 months, respectively, after the initial operation. One patient received a second transplant for primary graft failure at four days after the operation. A scoring system which considered the presence of pre-operative patient factors, such as coma, ascites, malnutrition and previous abdominal surgery, partly predicted the operative blood loss and patient survival. In conclusion, orthotopic liver transplantation is being performed in Australia with survival rates that are comparable with those of established overseas units.
原位肝移植于1985年1月在布里斯班开展。在该项目的头两年,一个评估委员会对55例患者(38名成人,17名儿童)进行了评估。患者要么被接受进行移植,要么因不适合而被拒绝,要么被推迟进行选择性重新评估。所有因病情“过于严重”而被拒绝移植的10名成人在评估后的四个月内死亡。6名被接受移植的儿童在找到合适的供体肝脏之前死亡。在头两年,对18例患者(成人13例;儿童5例)进行了21例原位肝移植。21例移植物中有15例取自昆士兰州境内。21例患者中有12例(67%)在3至23个月时存活,且均已出院。成人死亡原因包括败血症(3例)、吸入性肺炎(1例)、排斥反应和肝动脉血栓形成(1例)以及出院后五个月肝细胞癌复发(1例)。2例患者分别在初次手术后四个月和11个月因慢性排斥反应接受了第二次移植手术。1例患者在术后四天因原发性移植物功能衰竭接受了第二次移植。一种考虑术前患者因素(如昏迷、腹水、营养不良和既往腹部手术史)的评分系统在一定程度上预测了手术失血量和患者生存率。总之,澳大利亚正在开展原位肝移植,其生存率与国外成熟单位相当。